SH
BlackRock Health Sciences Opportunities Portfolio Service Shares
SHISX · NASDAQ
$64.85 +0.00% (+$0.00)
1M -3.80%
Market Cap ₹613.0B
P/E Ratio 30,424.60x
Div. Yield 14.84%
ROE -
Bulios Fair Price
$33.29
48.7% downside
Current Price
$64.85
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SHISX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
0 /100
Expensive P/S 328.07x
P/B 1,305.23x
P/E 30,424.60x
Growth
62 /100
Stable Rev. growth 17.58%
Book val. growth 94.14%
EPS growth 4.65%
Profitability
2 /100
Weak Op. margin 1.09%
Net margin 1.08%
FCF margin N/A
Quality
100 /100
Excellent Asset turnover 2.73x
ROA 2.95%
ROE N/A
Debt
100 /100
Low Current ratio 1.52x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
37 /100
Moderate Rev. volatility 20.81%
EPS volatility 127.29%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SHISX
Online
Sector
Financial Services
Industry
Asset Management
CEO
-
Employees
-
Headquarters
Wilmington